Showing results (991-1000 of 1,129) with videos related to

Sort By:
Pageof 113
Cancer Letters|April 26, 2021
Allogeneic hematopoietic cell transplant overcomes the poor prognostic value of CDKN2 deletion in adult B-lineage acute lymphoblastic leukemiaYiwen Ling, Na Xu, Ke Zhao, et al.
Plos Pathogens|September 12, 2025
Fish TOLLIP manipulates ATG5 for autophagic degradation of STING to attenuate antiviral interferon responsesMeng-Ze Tian, Yang-Yang Wang, Bao-Jie Cui, et al.
Cell Death & Disease|June 16, 2025
Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS/p-p38/NOXA/caspase-3/GSDME axisGaoyan Tang, Xuelei Cao, Jiaqi Chen, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 22, 2013
[Comparison of clinical implications of p16 deletion in childhood and adult B-lineage acute lymphoblastic leukemia]Xiao-zhen Xiao, Na Xu, Jin-fang Zhang, et al.
International Journal of Pharmaceutics: X|October 20, 2025
Nanoparticle-based drug delivery systems: A promising approach for the treatment of liver fibrosisYa-Ning Chen, Meng-Qi Li, Hui-Juan Zhang, et al.
International Journal of Hematology|March 10, 2011
Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from ChinaBin-Tao Huang, Yu Wang, Qing-Feng Du, et al.
Molecular Plant|June 11, 2021
Restriction of iron loading into developing seeds by a YABBY transcription factor safeguards successful reproduction in ArabidopsisLi Sun, Yun Qi Wei, Kang Hao Wu, et al.
International Journal of Cancer|December 1, 2019
Ponatinib therapy in recurrent Philadelphia chromosome-positive central nervous system leukemia with T315I mutation after Allo-HSCTJia-Bao He, Xin Zhang, Zi-Wen Guo, et al.
Orphanet Journal of Rare Diseases|June 19, 2026
Clinical characteristics and a screening tool for VEXAS syndrome: a case-control study from ChinaMenghui Yao, Min Shen, Chengjin Huang, et al.
Ebiomedicine|November 1, 2019
The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort studyShan Chen, Ke Zhao, Ren Lin, et al.
Pageof 113